Loading clinical trials...

Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis | Clinical Trials | Clareo Health

WITHDRAWNPhase 2NCT01574872

Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis

The purpose of this study is to evaluate the efficacy of Aerosal® compared to placebo in the prognosis of inverse psoriasis or sebopsoriasis present for at least one year

Lead sponsor: Tecno Sun SRL•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusWITHDRAWN

PhasePHASE2

Enrollment—

Start dateMar 2012

Last updatedNov 18, 2014

Condition

Inverse Psoriasis Sebopsoriasis

Locations shown

Fondazione S.Raffaele del Monte Tabor

Milan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions